Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
For women of reproductive age, the overall postpartum weight retention (weight gain between pregnancies) plays a significant role in long-term obesity. With 20% of women retaining ≥ 5 kg at 12 months postpartum, the risk of developing conditions, such as gestational diabetes mellitus (GDM), metabolic syndrome (MS) and subsequently diabetes and cardiovascular diseases, is substantially increased. In post-GDM mothers (women who had GDM in their recent pregnancy), postpartum weight retention is also an essential predictor of future diabetes.
Recent studies have identified the impact of circadian rhythms (influencing sleep/wake cycles) and diurnal rhythm of eating (when and how often calories are consumed over a 24h period) on cardio-metabolic disorders. In women, one remarkable feature of the postpartum period is an 'externally imposed' circadian misalignment of both sleep and eating rhythms, because most babies take several weeks to months to establish their daily pattern of activity and feeding, which is particularly relevant for breastfeeding women, as the responsibility is generally on the mother.
The overarching goal of this project is to explore the interplay between the diurnal rhythm of eating, circadian and metabolic parameters in humans. The potential postpartum effects of circadian disruption will be unraveled in women who had GDM during their pregnancy and those with an uneventful pregnancy. These women are subject to a circadian misalignment due to their 'externally imposed' changes in sleep/wake cycles and eating times in the postpartum period.
With a comprehensive approach combining molecular characterization of in vivo and in vitro circadian clock parameters along with metabolic, endocrine, transcriptomic, and lipidomic studies, the investigators will assess if eating duration and/or circadian misalignment impact on circadian clock parameters of postpartum women in a prospective cohort of 6 months.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Postpartum women who had gestational diabetes mellitus | Inclusion at 4-8 weeks postpartum Follow-up for 6 months | ||
| Postpartum women after an uneventful pregnancy | Inclusion at 4-8 weeks postpartum Follow-up for 6 months |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Eating duration | Duration from the first to last caloric intake over 24-hour cycle | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Correlation of in vitro circadian parameters (amplitude and magnitude) with clinical metabolic health outcomes (body weight) | Measured in cultured skin fibroblasts | At baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Sleep/wake cycles | Measured by actigraphy | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Sleep/wake cycles | Measured by the Pittsburgh Sleep Quality Index (scale 0-21, 0 indicating no sleeping difficulty, 21 indicating severe sleeping difficulties) |
| Measure | Description | Time Frame |
|---|---|---|
| Blood hormonal profile | Insulin and thyroid-stimulating hormone (mIU/L) | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Blood hormonal profile | Cortisol (nmol/L) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Postpartum women followed at the Lausanne University Hospital (CHUV)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jardena Puder, MD | University of Lausanne Hospitals | Principal Investigator |
| Tinh-Hai Collet, MD | University Hospital, Geneva | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lausanne University Hospital (CHUV) | Lausanne | 1011 | Switzerland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39531039 | Result | Phillips NE, Mareschal J, Biancolin AD, Sinturel F, Umwali S, Blanc S, Hemmer A, Naef F, Salathe M, Dibner C, Puder JJ, Collet TH. The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices. Diabetologia. 2025 Feb;68(2):419-432. doi: 10.1007/s00125-024-06318-x. Epub 2024 Nov 12. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016640 | Diabetes, Gestational |
| D024821 | Metabolic Syndrome |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood, serum and plasma Skin biopsy
| Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Body weight | Measured by bioelectrical impedance analysis | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Fat mass | Measured by bioelectrical impedance analysis | Changes between baseline and the close-out visit (i.e.changes between Month 0 and Month 6) |
| Fat-free mass | Measured by bioelectrical impedance analysis | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Physical activity (activity count per minute) | Measured by actigraphy | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Fasting glucose | Measured by clinical chemistry | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Lipid profile (concentration of total cholesterol, LDL cholesterol, triglycerides, HDL cholesterol) | Measured by clinical chemistry | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Glucose excursion (time-in-range, coefficient of variation) | Measured by continuous glucose monitoring | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Markers of lipid metabolism | Measured by high-throughput mass spectrometry lipidomics | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| Metabolomic parameters of energy metabolism | Measured by high-throughput mass spectrometry metabolomics | Changes between baseline and the close-out visit (i.e. changes between Month 0 and Month 6) |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |